RNF5 and acute myeloid leukemia: The additive effect on AML cell death of RNF5-KD plus FK228 treatment was lost upon RNF5 re-expression (Fig. 7g), confirming a specific role for RNF5 in sensitizing AML cells to HDAC inhibition.